AI-Powered sperm selection could boost IVF success
NCT ID NCT06990906
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests an AI-driven device called BAIBYS™ that automatically selects sperm based on movement, size, and shape for use in IVF. Half of the eggs from each couple will be fertilized using sperm chosen by the AI, and the other half using the standard manual method. The goal is to see if the AI leads to more usable embryos and higher pregnancy rates. The trial involves 260 couples where the male partner has abnormal sperm parameters.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
BAIBYS™ System (AI-based sperm selection device)
What this could lead to
If successful, this AI tool could make sperm selection faster and more consistent, potentially leading to higher-quality embryos and more successful pregnancies in IVF.
What could go wrong
This is an early-stage study with 260 participants, so results may not apply to everyone. The device could malfunction or not improve outcomes as hoped, and there is a small risk of serious adverse events.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALE INFERTILITY, AZOOSPERMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Assuta Medical Center
Tel Aviv, 6971028, Israel
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Care Fertility Group
Manchester, United Kingdom
-
New England Fertility Institute
Stamford, Connecticut, 06905, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••